Stroke Journal

MARCH 23, 2025

The longstanding benefits of percutaneous angioplasty and stenting in coronary artery disease, where atherosclerosis is the overarching cause in nearly all cases, provided a compelling rationale for exploring similar interventions in intracranial atherosclerotic stenosis.

Angioplasty 40

Angioplasty Stenosis Coronary Artery Disease Stents 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

We included articles reporting patients > 18 years old with symptomatic extracranial vertebral artery stenoses due to atherosclerosis treated with stenting (with or without angioplasty). Those reporting patients with vertebral dissections were excluded.

Angioplasty 40

Angioplasty Stents Stent Stenosis 40

Stroke: Vascular and Interventional Neurology

JANUARY 25, 2024

Most respondents (86%) preferred acute treatment of ICAS‐LVO with rescue stenting (RS)±angioplasty. Fear of hemorrhagic complications (74%) was the most compelling reason not to perform RS±angioplasty. Stroke: Vascular and Interventional Neurology, Ahead of Print.

Atherosclerosis 40

Atherosclerosis Angioplasty Stenosis Biomarkers 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionIntracranial atherosclerosis‐related large vessel occlusion (ICAS‐LVO) is a common cause of failed mechanical thrombectomy (MT) in acute ischemic stroke (AIS) [1]. Treatment of ICAS‐LVO with rescue stenting and/or angioplasty has shown promising outcomes, but diagnosing ICAS‐LVO during MT can be challenging [2, 3].

Atherosclerosis 40

Atherosclerosis Angioplasty Biomarkers Stent 40

Stroke Journal

JUNE 26, 2024

For decades, the ACAS (Asymptomatic Carotid Atherosclerosis Study) and ACST (Asymptomatic Carotid Surgery Trial) trials provided most of the evidence supporting endarterectomy for patients with asymptomatic high-grade stenosis who were otherwise good candidates for surgery. Stroke, Ahead of Print.

Stenosis 40

Stenosis Stents Stent Atherosclerosis 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionIntracranial atherosclerosis (ICAS) is a leading global cause of stroke. In the SAMMPRIS trial, patients who had experienced recent TIA/CVA secondary to 70‐99% ICAS demonstrated an increased risk of recurrent stroke when treated with angioplasty and stenting compared to medical therapy alone [1].

Stents 40

Stents Stent Outcomes Angioplasty 40

Heart 2023 Conference

APRIL 20, 2022

American College of Cardiology Journal) Are you thinking of stopping your antiplatelet medication too soon after angioplasty? Reconsider your position. The American Heart Association draws attention to nonalcoholic fatty liver disease, which affects about one in four adults and is a risk factor for atherosclerotic cardiovascular disease.

Pulmonary 52

Pulmonary Hypertension AFIB COVID-19 52